Feature: Life up close
10 June, 2011 by Tim DeanAssociate Professor Cynthia Whitchurch and Dr Lynne Turnbull are helping to reveal new insights into the smallest features of life care of their new super resolution DeltaVision|OMX microscope.
Comment: Are you ready for the resurgence in Australian life sciences M&A?
07 June, 2011 by Staff WritersFor Australian life sciences companies, the importance of being deal ready is more pressing than at any time since the middle of the last decade.
Super resolution microscopy pinpoints T cell trigger
06 June, 2011 by Tim DeanResearchers at the University of New South Wales have identified the molecular switch that kicks T cells into action using super-resolution fluorescence microscopy.
Federal government renews commitment to Commercialisation Australia
18 May, 2011 by Staff WritersThe government has committed to allocating $278 million over five years to Commercialisation Australia, with some expected to flow to biotechs.
Australia and China commit to joint science fund
28 April, 2011 by Staff WritersThe Australian and Chinese governments will commit $9 million each to a new Australia-China Science and Research Fund from 2011-12.
Australia gets a new Chief Scientist
19 April, 2011 by Tim DeanFormer vice-chancellor of the Australian National University, Professor Ian Chubb AC, has been appointed Chief Scientist.
Slideshow: Rally for Research attracts big crowds
13 April, 2011 by Tim DeanScientists and the general public gather at the Rally for Research in Melbourne to show support for health and medical research and to protest proposed cuts to the NHMRC budget.
Sigma Pharmaceuticals jumps 10% on positive results
28 March, 2011 by IDG Online StaffSigma Pharmaceuticals (ASX:SIP) end of year numbers were well received by the market today with shares rising 4.5c to close at 46c, on markedly improved results compared to prior year.
Australian government to overhaul clinical trials
03 March, 2011 by Tim DeanThe federal government will overhaul the clinical trials process in Australia after accepting recommendations of the long awaited Clinical Trials Action Group report.
Shock at Chief Scientist's surprise resignation
18 February, 2011 by Tim DeanAustralia's Chief Scientist, Professor Penny Sackett, has stunned the scientific community with her sudden resignation today.
Prime Minister's Prizes for Science nominations open
18 February, 2011 by Staff WritersNominations are now open for the prestigious Prime Minister's Prizes for Science.
Managing acquisition - how to get it right
17 February, 2011 by Matthew SainsburyAcquisitions are commonplace in the IT industry. ARN investigates what makes the difference between a successful acquisition or merger, and where things can (and do) go wrong.
bioMD makes a bid for Andrew Forest's Allied Medical and Coridon
15 February, 2011 by Staff WritersbioMD is looking to acquire Allied Medical, which also owns Coridon, led by Ian Frazer, to produce a new diversified healthcare company.
Feature: To be a lab manager
11 February, 2011 by David BinningKeeping a life science lab running smoothly and safely has become an increasingly complex and demanding task.
Danaher to acquire Beckman Coulter for US$6.8 billion
09 February, 2011 by Staff WritersUS technology company, Danaher, is to acquire Beckman Coulter in a deal worth US$6.8 billion.
